These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 25694097)

  • 1. Pharmacotherapy of Ebola hemorrhagic fever: a brief review of current status and future perspectives.
    Olszanecki R; Gawlik G
    Folia Med Cracov; 2014; 54(3):67-77. PubMed ID: 25694097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ebola virus disease].
    Nazimek K; Bociaga-Jasik M; Bryniarski K; Gałas A; Garlicki A; Gawda A; Gawlik G; Gil K; Kosz-Vnenchak M; Mrozek-Budzyn D; Olszanecki R; Piatek A; Zawilińska B; Marcinkiewicz J
    Folia Med Cracov; 2014; 54(3):5-16. PubMed ID: 25694090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Will There Be a Cure for Ebola?
    Cardile AP; Warren TK; Martins KA; Reisler RB; Bavari S
    Annu Rev Pharmacol Toxicol; 2017 Jan; 57():329-348. PubMed ID: 27959624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current status of drug treatment against the disease caused by the Ebola virus].
    Reina J
    Rev Esp Quimioter; 2016 Feb; 29(1):1-7. PubMed ID: 26785224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ebola haemorrhagic fever virus: pathogenesis, immune responses, potential prevention.
    Marcinkiewicz J; Bryniarski K; Nazimek K
    Folia Med Cracov; 2014; 54(3):39-48. PubMed ID: 25694094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model.
    Oestereich L; Lüdtke A; Wurr S; Rieger T; Muñoz-Fontela C; Günther S
    Antiviral Res; 2014 May; 105():17-21. PubMed ID: 24583123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Marburg and Ebola hemorrhagic fevers--pathogens, epidemiology and therapy].
    Stock I
    Med Monatsschr Pharm; 2014 Sep; 37(9):324-30; quiz 331-2. PubMed ID: 25282746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of ebola virus disease.
    Kilgore PE; Grabenstein JD; Salim AM; Rybak M
    Pharmacotherapy; 2015 Jan; 35(1):43-53. PubMed ID: 25630412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene-specific countermeasures against Ebola virus based on antisense phosphorodiamidate morpholino oligomers.
    Warfield KL; Swenson DL; Olinger GG; Nichols DK; Pratt WD; Blouch R; Stein DA; Aman MJ; Iversen PL; Bavari S
    PLoS Pathog; 2006 Jan; 2(1):e1. PubMed ID: 16415982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recent Advances in Vaccines and Drugs Against the Ebola Virus].
    Zhu X; Yao C; Wei Y; Kou Z; Hu K
    Bing Du Xue Bao; 2015 May; 31(3):287-92. PubMed ID: 26470536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addressing Therapeutic Options for Ebola Virus Infection in Current and Future Outbreaks.
    Haque A; Hober D; Blondiaux J
    Antimicrob Agents Chemother; 2015 Oct; 59(10):5892-902. PubMed ID: 26248374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perspectives towards antiviral drug discovery against Ebola virus.
    Mirza MU; Vanmeert M; Ali A; Iman K; Froeyen M; Idrees M
    J Med Virol; 2019 Dec; 91(12):2029-2048. PubMed ID: 30431654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression of Ebola Therapeutics During the 2014-2015 Outbreak.
    Mendoza EJ; Qiu X; Kobinger GP
    Trends Mol Med; 2016 Feb; 22(2):164-173. PubMed ID: 26774636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The evolution of Ebola virus disease outbreaks.
    Gałas A
    Folia Med Cracov; 2014; 54(3):27-32. PubMed ID: 25694092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ebola Virus Infection: Review of the Pharmacokinetic and Pharmacodynamic Properties of Drugs Considered for Testing in Human Efficacy Trials.
    Madelain V; Nguyen TH; Olivo A; de Lamballerie X; Guedj J; Taburet AM; Mentré F
    Clin Pharmacokinet; 2016 Aug; 55(8):907-23. PubMed ID: 26798032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ebola virus - epidemiology, diagnosis, and control: threat to humans, lessons learnt, and preparedness plans - an update on its 40 year's journey.
    Singh RK; Dhama K; Malik YS; Ramakrishnan MA; Karthik K; Khandia R; Tiwari R; Munjal A; Saminathan M; Sachan S; Desingu PA; Kattoor JJ; Iqbal HM; Joshi SK
    Vet Q; 2017 Dec; 37(1):98-135. PubMed ID: 28317453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Drug Targets and Antiviral Molecules for Treatment of Ebola Virus Infection.
    Wu W; Liu S
    Curr Top Med Chem; 2017; 17(3):361-370. PubMed ID: 27572081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small molecule inhibitors of ebola virus infection.
    Picazo E; Giordanetto F
    Drug Discov Today; 2015 Feb; 20(2):277-86. PubMed ID: 25532798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of treatment strategies to combat Ebola and Marburg viruses.
    Paragas J; Geisbert TW
    Expert Rev Anti Infect Ther; 2006 Feb; 4(1):67-76. PubMed ID: 16441210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The determinants of spread of Ebola virus disease - an evidence from the past outbreak experiences.
    Gałas A
    Folia Med Cracov; 2014; 54(3):17-25. PubMed ID: 25694091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.